Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis

Fig. 2

The main steps in the identification and selection of biomarker candidate proteins for inclusion in the PRM assays. Screenshots are from CSF-PR [14], PPI network is from [5] and other figures are from Servier Medical Art licensed under a Creative Commons Attribution 3.0 Unported License. TMT = tandem mass tag, DDA = data dependent acquisition, MM-RP AX = mixed-mode reversed-phase anion exchange [18], GO = gene ontology, ECM = Extracellular matrix

Back to article page

Clinical Proteomics

ISSN: 1559-0275